05-11-2021, 07:16 AM
Moderna (NASDAQ:MRNA) stock slumped 11% after the vaccine maker cut its full-year sales forecast for its Covid-19 vaccine to between $15 billion and $18 billion from $20 billion, amid difficulties with the production of its two-dose inoculation.
Regeneron (NASDAQ:REGN) stock rose 2.4% after the biotech company reported that its third-quarter profit nearly doubled, boosted by strong sales of its drugs, including its Covid-19 antibody offering.
https://finance.yahoo.com/news/moderna-s...54744.html
Regeneron (NASDAQ:REGN) stock rose 2.4% after the biotech company reported that its third-quarter profit nearly doubled, boosted by strong sales of its drugs, including its Covid-19 antibody offering.
https://finance.yahoo.com/news/moderna-s...54744.html